MRNA
Moderna, Inc. · Healthcare
Director Noubar Afeyan sold $256.4M of Moderna, Inc.
Sold$256,378,924
$146.19Price
1,753,697Shares
−6%Stake
What MRNA did after the filing
- The stock from Thu, Feb 25 open, $150.78
- −6.5%
- S&P 500, same days
- +5.7%
Measured over 30 trading days, to the Apr 9 close.
Traded Wed, Feb 24. Filed Wed, Feb 24. Returns use the Feb 25 open and the Apr 9 close. Not investment advice.